To stay up to date about upcoming podcasts and events, join our Facebook groups:

ADULT AML

AML CAREGIVERS

HealthTree Podcast for AML Episode

Kendra Sweet, MD
Moffitt Cancer Center
Interview Date: June 9, 2022

Thanks to Our Episode Sponsor

Show Summary

Immunotherapy continues to be an expanding and evolving area of research for AML with many drugs in development. In this show, Dr. Kendra Sweet, an AML expert from Moffitt Cancer Center, shared with us about an antibody drug conjugate called IMGN632 and the current trials using this drug.  IMGN632 targets CD123-positive AML cells and has shown promising results in relapsed/refractory patients in previous AML trials. 

Listen to the Full Show:

*Full Show Transcript Coming Soon*

Join the HealthTree Podcast for AML Chapter to receive emails on upcoming episodes:

SIGN UP HERE